ACRS Breakout Stock Sell Alert
BREAKOUT STOCK SELL ALERT
ACRS - Aclaris Therapeutics, Inc. - Common Stock
Initial Alert Price: $3.46
Price High: $19.80
% Gains/Losses: 472.25%
(+450% More Than Expected)
ACRS topped out at $19.80 in Today's Trading Session providing a 454% Return on our Initial Trade Alert from Dec. 1st when the stock once only $3.46. This comes after the company announced that its ATI-450 drug candidate demonstrated "durable clinical activity" in a phase 2a trial in patients with moderate to severe rheumatoid arthritis over a 12-week period. We are seeing signals of Profit-Taking/Consolidation from today's run, so we suggest staying on high-alert watching this stock moving forward, as we will be adding it to our watchlist for another potential re-entry after consolidation completes.
#Breakout #Stocks #Trading #Investing #Alerts #StockMarket #Daily #News #Today
ACRS - Aclaris Therapeutics, Inc. - Common StockInitial Alert Price: $3.46
Price High: $19.80
% Gains/Losses: 472.25%
(+450% More Than Expected)
ACRS topped out at $19.80 in Today's Trading Session providing a 454% Return on our Initial Trade Alert from Dec. 1st when the stock once only $3.46. This comes after the company announced that its ATI-450 drug candidate demonstrated "durable clinical activity" in a phase 2a trial in patients with moderate to severe rheumatoid arthritis over a 12-week period. We are seeing signals of Profit-Taking/Consolidation from today's run, so we suggest staying on high-alert watching this stock moving forward, as we will be adding it to our watchlist for another potential re-entry after consolidation completes.
#Breakout #Stocks #Trading #Investing #Alerts #StockMarket #Daily #News #Today
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.